Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible for some patients.

and the 5 milligram vial will now be priced at $499, according to a release. Patients must use a syringe and needle to draw up the medicine from a single-dose vial and inject themselves.

The American pharmaceutical company has started selling higher doses of Zepbound, as it seeks to spur demand for the medicine ...

That is nearly 23% less than the $650 Lilly charges for auto-injectors of the drug to patients who are insured but not covered for the medicine. The U.S. drugmaker last August launched vials of ...

roughly 23% cheaper than the $650 it charges for its injector pen to insured patients whose coverage does not include the medicine. Self-pay patients with obesity now have additional vial options ...

Eli Lilly began offering vials of the two lowest doses of Zepbound ... drug to patients who are insured but not covered for the medicine. Patrik Jonsson, Eli Lilly's president of cardiometabolic ...